pfo
Showing 1 - 5 of 5
Lifetech Cera™ PFO Occluder Post-Market Clinical Follow-Up
Not yet recruiting
- Patent Foramen Ovale
- PFO
- The Cera™ PFO Occluder
- (no location specified)
May 30, 2023
Patent Foramen Ovale, PFO Trial (Device closure with the AMPLATZER PFO Occluder)
Approved for marketing
- Patent Foramen Ovale
- PFO
- Device closure with the AMPLATZER PFO Occluder
- (no location specified)
Apr 9, 2019
Migraine, Migraine With Aura, Patent Foramen Ovale Trial in Worldwide (AMPLATZER® PFO Occluder Device)
Terminated
- Migraine
- +3 more
- AMPLATZER® PFO Occluder Device
-
Calgary, Alberta, Canada
- +16 more
Feb 1, 2019
Patent Foramen Ovale, PFO, Stroke Trial in Hillerød (Percutaneous device closure of patent foramen ovale)
Terminated
- Patent Foramen Ovale
- +3 more
- Percutaneous device closure of patent foramen ovale
-
Hillerød, Region H, DenmarkDept. of cardiology and endocrinology H
May 5, 2010
PFO, Stroke, Transient Ischemic Attack Trial in Frankfurt (PFx Closure System)
Suspended
- PFO
- +4 more
- PFx Closure System
-
Frankfurt, GermanyCardiovascular Center Frankfurt Sankt katharinen
Dec 18, 2007